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Abstract
PU.1 is an ETS family transcription factor important for the development of multiple 
hematopoietic cell lineages. Previous work demonstrated a critical role for PU.1 in promoting Th9 
development, and in limiting Th2 cytokine production. Whether PU.1 has functions in other T 
helper lineages is not clear. In this report we examined the effects of ectopic expression of PU.1 in 
CD4+T cells and observed decreased expression of genes involved with the function of T 
follicular helper (Tfh) cells, including Il21 and Tnfsf5 (encoding CD40L). T cells from conditional 
mutant mice that lack expression of PU.1 in T cells (Sfpi1lck−/−) demonstrated increased 
production of CD40L and IL-21 in vitro. Following adjuvant-dependent or adjuvant-independent 
immunization, we observed that Sfpi1lck−/− mice had increased numbers of Tfh cells, increased 
germinal center B cells, and increased antibody production in vivo. This correlated with increased 
expression of IL-21 and CD40L in Tfh cells from Sfpi1lck−/− mice, compared to control mice. 
Finally, although blockade of IL-21 did not affect germinal center B cells in Sfpi1lck−/− mice, anti-
CD40L treatment of immunized Sfpi1lck−/− mice decreased germinal center B cell numbers and 
antigen-specific immunoglobulin concentrations. Together, these data indicate an inhibitory role 
of PU.1 in the function of T follicular helper cells, germinal centers, and Tfh-dependent humoral 
immunity.
Introduction
Transcription factors are essential components of cellular development and differentiation. 
Typically, networks of transcription factors work together within the nucleus of a cell 
orchestrating the establishment of characteristics that define the phenotype of a cell. The 
CD4+ T helper (Th) subsets, Th1 and Th2 cells, require the transcription factors T-bet and 
GATA3 for differentiation. RORγt promotes the differentiation of Th17 cells, Foxp3 
functions as a master transcription factor in T-regulatory cells, and there is a requirement for 
Bcl6 in T follicular helper (Tfh) cell differentiation (1-3). PU.1 is a transcription factor that 
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belongs to the E-twenty six (ETS) family of proteins, and we have shown that PU.1 is 
crucial for the differentiation of the IL-9-producing, Th9 subset, in humans and mice (4, 5). 
Although, these transcription factors are of great importance in their respective cell types, 
the activity of T-bet alone in Th1 cells for example, is insufficient for induction of the 
complete Th1 phenotype (6). Additional factors are necessary to induce and regulate the 
phenotype and functions of the different Th subsets. Since the discovery of Bcl6 as the 
master transcription factor in Tfh cells, extensive investigation has focused on identifying 
additional factors that positively or negatively regulate the development of Tfh cells.
Tfh cells were first proposed as a Th subset more than a decade ago (7, 8). Tfh cells have the 
unique function of providing help to B cells that bind the same antigen and this interaction 
occurs in specialized areas termed germinal centers. In addition to Bcl6, a variety of 
transcription factors, cytokines and receptor-ligand interactions also play a crucial role in 
establishment of the Tfh phenotype and germinal center activity. BLIMP1 is a transcription 
factor that negatively regulates Tfh cell development by antagonizing Bcl6 activity (1). 
IRF4, c-MAF, and STAT3 positively regulate Tfh cell development, and the absence of 
these transcription factors drastically impairs Tfh differentiation and thus germinal center 
development (9-15). IL-21 is a cytokine that is expressed by Tfh cells that facilitates the 
ability of Tfh cells to help germinal center B (GCB) cells survive and undergo class-
switching recombination. In the absence of IL-21, differentiation of GCB cells is impaired, 
although Tfh cells are only modestly impacted (16-18). The necessity of IL-21 within the 
germinal center parallels the requirement of CD40L for proper germinal center 
development. Interaction of CD40L with its cognate partner CD40 expressed on GCB cells 
promotes the survival and proliferation of GCB cells. The interaction between CD40 and 
CD40L is essential for initiation and progression of germinal center activity (19, 20). 
However, the transcriptional regulation of IL-21 and CD40L in Tfh cells is not well 
understood.
PU.1 is expressed in thymic precursors, but expression is extinguished during thymic T cell 
development at the DN2 stage, regulation that is necessary for T cells to develop (21). 
However, PU.1 is expressed in mature peripheral T cells and expression is induced by T cell 
activation and culture of T cells with specific cytokines, including the cytokines that 
promote Treg, Th9 and Th2 development (4, 22-25). When mice with a conditional allele of 
PU.1 (Sfpi1) are mated to an Lck-Cre transgenic, the gene is deleted at the DN3-DN4 stage 
of thymic development, stages when deletion would not be expected to have an effect (26). 
Despite deletion, thymic and peripheral T cell populations are normal. PU.1-deficient T cells 
have a lower activation threshold under limiting TCR stimulation, owing to increases in 
TCR expression (22). Although Th1, Th17 and Treg development appears normal, PU.1 
promotes Th9 development and limits heterogeneity in Th2 populations (4, 22, 23). Whether 
PU.1 has functions in additional Th lineages is not known. In this report we define a role for 
PU.1 in limiting Tfh development, IL-21 and CD40L expression in Tfh cells, and in the 
germinal center response.
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Materials and Methods
Mice
C57BL/6 mice (WT) were purchased from Harlan Bioscience. PU.1 conditional mutant mice 
were generated by crossing Sfpi1 fl/fl mice on the C57BL/6 background with mice 
containing the Cre recombinase transgene under the control of the Lck promoter (4, 27). 
Mice were kept in a pathogen-free environment, and all studies were approved by the 
Animal Care and Use Committee of the Indiana University School of Medicine.
T helper Cell Differentiation
Naïve CD4+CD62L+ T cells were isolated from spleen and lymph nodes by magnetic 
separation using kits that employ negative selection (Miltenyi Biotech). Naïve cells were 
cultured in complete RPMI-1640 medium (supplemented with 10% (vol/vol) FBS (Atlanta 
Biologicals), 1mM glutamine (BioWhittaker), 100 U/mL penicillin (BioWhittaker), 100 
μg/mL of streptomycin (BioWhittaker), 10mM HEPES, pH 7.3 (BioWhittaker), 1 mM 
sodium pyruvate (BioWhittaker) and 50 μM 2-mercaptoethanol) on α-CD3 (2μg/mL; 
145-2C11; BioXcell) coated plates in the presence of soluble α-CD28 (1-2μg/mL) under 
Th1 (5ng/mL IL-12; 50 U/mL IL-2 and 10 μg/mL anti-IL-4, 11B11), Th2 (10ng/mL IL-4; 
and 10μg/mL anti-IFN-γ, XMG), Th9 (10 ng/mL IL-4; 2ng/mL TGF-β; and 10μg/mL anti-
IFN-γ, XMG) , Th17 (100ng/mL IL-6; 10 ng/mL IL-1β; 2ng/mL TGF-β; 10μg/mL anti-IFN-
γ, XMG; 10μg/mL and anti-IL-4, 11B11) and T regulatory cell conditions (2ng/mL TGF-β;
10μg/mL anti-IFN-γ, XMG; 10μg/mL and anti-IL-4, 11B11). Cells were expanded after 
three days with fresh media and cytokines for Th1 (media only), Th2 (media only), Th17 
(50ng/mL IL-6; 5ng/mL IL-1β; and 20U/mL of IL-2) Th9 (10ng/mL IL-4; 2ng/mL TGF-β; 
and 50U/mL IL-2), and T-regulatory cells (50U/mL IL-2). After 5 days, cells were 
restimulated on α-CD3 coated plates for 24 hours, and supernatants were collected for 
ELISA. For CD40L staining, naïve CD4+ T cells were stimulated with PMA (50ng/mL) and 
Ionomycin (500ng/mL) for 2 hours. Cells were either stained for surface CD4 (RM4-5) and 
CD40L expression or permeabalized for intracellular CD40L staining. For Tfh-like cell 
culturing, naïve cells were cultured in complete RPMI-1640 medium on anti-CD3 (10 
μg/mL; 145-2C11; BioXcell) and anti-CD28 (10 μg/mL) coated plates under Tfh–like cell 
conditions (100 ng/mL IL-6; 50 ng/mL IL-21; 10 μg/mL anti-IL-2, anti-IFN-γ, anti-IL-4, 
and anti-TGF-β).
Retroviral transduction
Bicistronic retroviral expression vectors expressing either eGFP (MIEG), or hCD4 in 
combination with the mouse gene for PU.1, Sfpi1 (MIEG- Sfpi1), were described previously 
(23). Th cells cultured in Th17 conditions were transduced with retroviral supernatant, 
MIEG or MIEG- Sfpi1, 2 days after culturing in the presence of 8 μg/mL polybrene. Cells 
were also given IL-2 and expanded 3 days after culturing. After 5 days, cells were sorted 
based on GFP expression and stimulated on α-CD3 coated plates for 24 hours. Supernatants 
were collected for ELISA.
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Chromatin Immunoprecipitation
ChIP assay was performed as previously described (25). Immunoprecipitations were 
performed with rabbit polyclonal antibodies (control IgG or PU.1 [T-21])(Santa Cruz 
Biotechnology Inc.). Quantification of binding DNA was performed with SYBR Green Fast 
PCR Master Mix using the ABI 7500 Fast Real-time PCR System (both from Applied 
Biosystems). Tnfsf5 primers (364 bp upstream from TSS) were as follows: (forward) 5′ 
AAC-TGG-TGA-ACC-CCA-AAC-TTT-A 3′ and (reverse) 5′ CAC-CCA-TAT-CAT-TCA-
CTT-CCA-G 3′. Pdcd1 primers (1168 bp upstream from TSS) were as follows: (forward) 5′ 
TAA-TGT-TTC-CTT-CCC-CAC-CA 3′ and (reverse) 5′CTG-GGG-CAT-TCT-GAT-GAT-
TT 3′. Il21 primers (437 bp upstream from TSS) were as follows: (forward) 5′ TGC-CGC-
TGC-TTT-ACT-CAT-TG 3′ and (reverse) 5′ GCA-CCG-TCA-GCT-TTC-AGA-GA 3′. To 
quantify immunoprecipitated DNA, a standard curve was generated from serial dilutions of 
input DNA. To calculate ChIP results as a percentage of input, the amount of the 
immunoprecipiated DNA from the IgG control was subtracted from the amount of the 
immunoprecipitated DNA from the PU.1 antibody, followed by normalizing against the 
amount of the input DNA.
MOG35-55 peptide and SRBC immunizations
Mice were immunized with 100-150 μg of MOG35-55 peptide (Genemed Synthesis) 
subcutaneously (s.c.) with in an emulsion of complete Freud’s Adjuvant (CFA) containing 
1mg/mL of heat killed H37RA strain of Mycobacterium tuberculosis (Sigma-Aldrich) in the 
hind leg region. Pertussis toxin (List Biological Laboratories, Inc) in PBS was injected 
intraperitoneally (i.p.) at a dose of 100-250 μg on the day of immunization and again 2 days 
after. sRBC (VWR Intl.) immunizations were done with 1 × 109 sRBC injected i.p. After 7 
days, mice were sacrificed and splenocytes stained with Tfh and GC B cell markers.
Surface and Intracellular Staining
Splenocytes were treated with Fc-block for 5 minutes at RT and stained with Tfh markers 
CXCR5 (SPRCL5, Biolegend), CD4 (RM4-5, Biolegend), PD-1 (J43, Biolegend), and ICOS 
(C398.4A, eBioscience). CXCR5 staining was carried out at RT for 45 minutes and washed. 
Antibodies for CD4, PD-1, and ICOS were subsequently added. GCB cells were stained 
with Fas at 40 for 45 minutes, washed, and stained for B220 and GL-7. Cells were 
stimulated for 2 or 4 hours in the presence of PMA and Ionomycin for CD40L (MR1) and 
IL-21 staining, respectively. After 1 hour and 2 hours, for CD40L and IL-21 staining, 
respectively, cells were treated with 3μM monensin. After stimulation cells were surface 
stained for Tfh markers, and stained for IL-21. IL-21 staining was conducted using the 
IL-21R-human IgG chimera (R&D systems) with PE-anti-Human Fc gamma (eBiosciences) 
as the secondary antibody as described previously (28).
Tfh Gene Expression
Wild-type and PU.1lck−/− mice were given one injection of 1 × 109 SRBCs i.p. Seven days 
after immunization mice were sacrificed and splenocytes were stained with CXCR5, CD4, 
and PD-1 antibodies. CD4+CXCR5HighPD-1High (Tfh) and CD4+CXCR5−PD-1− (non-Tfh) 
cells were sorted by flow cytometry. RNA from sorted cells was isolated with Trizol to 
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generate cDNA. Quantitative PCR was conducted to measure gene expression and results 
are relative to expression of β2-microglobulin as an internal control.
CD40L Blocking Experiments
Wild type and PU.1lck−/− mice were given one injection of 1 × 109 sRBCs i.p. CD40L 
blocking antibody (MR1, BioXcell) or control antibody (hamster IgG, BioXcell) were given 
i.p. on days 5 and 6 at concentration of 250μg/mL in PBS on each day. Mice were sacrificed 
on day 7, serum was collected to determine antibody titer and splenocytes were stained for 
Tfh and GCB cell markers.
Statistical analysis
The Student’s two-tailed t-test was used for pairwise statistical comparison or ANOVA for 
comparisons of multiple groups. p values of 0.05 or less were considered as significant.
Results
PU.1 regulates the expression of CD40L and IL-21
Although PU.1 induces IL-9 production in Th9 cells, whether it has functions in other Th 
subsets is not known. Results from a study comparing Th2 cells with ectopically expressed 
PU.1 to control cells demonstrate that PU.1 can activate and repress gene expression in T 
cells (Figure 1A). Consistent with our previous reports (4, 22, 23) we observed repression of 
Th2 cytokine genes and induction of chemokines associated with type 2 inflammation 
(Figure 1A). Among other PU.1-repressed genes we observed genes encoding CD40L 
(Tnfsf5) and IL-21. To determine if ectopic expression of PU.1 regulates the protein 
expression of a subset of these genes, we compared the expression of CD40L and PD-1 
(Pdcd1) on the surface of control and PU.1 transduced T cells cultured under Tfh-like 
conditions. We observed PU.1 repressed expression of both surface receptors (Figure 1B). 
We performed similar experiments ectopically expressing PU.1 in naïve CD4+ T cells 
isolated from mice with a conditional allele of Sfpi1 that encodes PU.1 crossed to an Lck-
Cre transgenic strain (termed Sfpi1lck−/− mice) cultured under Th17 conditions. Retroviral 
expression of PU.1 in Sfpi1lck−/− cells decreased IL-21 production, but did not affect 
production of IL-17A or IFNγ Figure 1C). To determine if PU.1-dependent regulation of 
these genes was potentially through a direct mechanism, we performed ChIP assays for PU.1 
and assessed binding to regulatory elements in Tnfsf5, Il21, and Pdcd1. Comparing binding 
in wild type and Sfpi1lck−/− T cells, we observed significant binding of PU.1 at the Tnfsf5 
and Il21 promoters but not at the Pdcd1 gene (Figure 1D).
To investigate whether endogenous PU.1 regulates the expression of CD40L in CD4+T 
cells, CD4+ T cells were isolated from wild type and Sfpi1lck−/− mice and stimulated with 
PMA and Ionomycin for 2 hours. After 2 hours of stimulation, surface and intracellular 
CD40L expression was determined by flow cytometry. An increase in the percentage of 
CD4+ cells that stained positive for CD40L was observed when stimulated CD4+ cells from 
Sfpi1lck−/− mice were compared to cells from wild type mice (Figure 2A-B). The CD40L 
mean fluorescence intensity (MFI) of cells that were CD40L+ was also increased in 
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stimulated CD4+ cells from Sfpi1lck−/− mice (Figure 2C). These data demonstrate that PU.1 
limits the expression of CD40L in CD4+ T cells.
Many Th subsets express IL-21 (28-31). We differentiated Th1, Th2, Th9, Th17 and T-
regulatory cells in vitro for 5 days, restimulated equal numbers of cells on anti-CD3 coated 
plates for an additional 24 hours, and collected supernatants to measure IL-21 using ELISA. 
Th17 cells derived from Sfpi1lck−/− mice produced significantly more IL-21 compared to 
wild type T cells (Figure 2D). However, IL-17A production in Th17 cultures was similar 
between both groups (Figure 2E). In parallel experiments, naïve T cells from wild type and 
Sfpi1lck−/− mice were cultured under conditions to generate Tfh-like cells and we observed a 
greater percentage of IL-21-positive PD-1-positive cells in cultures that lacked PU.1 
expression (Figure 2F). Thus, PU.1 regulates the expression of CD40L and IL-21.
MOG35-55 immunized Sfpi1lck−/− mice show decreased resolution of germinal center 
activity
CD40L and IL-21 promote germinal center activity and germinal center B-cell 
differentiation (16, 17, 19, 20, 32). The cognate interaction between CD40-expressing GCB 
cells and CD40L-expressing Tfh cells is important for germinal center B cell survival, 
proliferation, and maturation. Lack of CD40L expression in humans and mice impairs 
proper germinal center formation and function (19, 33-37). IL-21 also contributes, though is 
not essential for the differentiation and expansion of GCB cells (32). The findings that PU.1 
can regulate CD40L and IL-21 expression led us to hypothesize that PU.1 may be important 
in Tfh and germinal center activity. To investigate if PU.1 has any impact on Tfh 
development, wild type and Sfpi1lck−/− mice were immunized with an emulsion containing 
myelin oligodendricyte glycoprotein (MOG) peptide in CFA. At several time points after 
immunization the spleens from wild type and Sfpi1lck−/− mice were analyzed for expression 
of Il21 and Tnfsf5 by qPCR. Il21 expression in splenocytes from immunized Sfpi1lck−/− 
mice was significantly increased at 12 and 25 days after immunization, compared to 
splenocytes from wild type mice (Figure 3A). Tnfsf5 expression was also higher compared 
to wild type mice (Figure 3A). We then examined splenic Tfh cells using flow cytometry. 
Sfpi1lck−/− mice showed increased percentages and absolute numbers of Tfh cells 
(CD4+CXCR5+PD-1+) 12 days after immunization compared to wild type mice, with no 
significant differences in total splenic cellularity (Figure 3B-C). The increase in the 
percentage of Tfh cells in Sfpi1lck−/− mice persisted on Days 25 and 28, although absolute 
numbers of Tfh cells were not significantly different at the later time points (Figure 3B-C). 
The MFI of PD-1 and ICOS expressed on the surface of Tfh cells was greater in Sfpi1lck−/− 
compared to wild type mice (Figure 3D).
To determine if increased Tfh numbers and function resulted in increased germinal center B 
(GCB) cells, we examined GCB populations using flow cytometry and antigen-specific 
antibody production in the serum. We observed increased GCB cells in Sfpi1lck−/− 
compared to wild type mice beginning on day 12 (Figure 4A-B). The percent of GCB in 
Sfpi1lck−/− mice increased over the 28 day period examined and was significantly greater 
than observed in wild type mice at all time points (Figure 4A-B). The absolute number of 
GCB cells was also significantly increased at day 12 and 28 (Figure 4B). In agreement with 
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the increase in GCB cells, we also observed increased MOG35-55-specific IgG titers at day 
12 (Figure 4C) and increased MOG35-55-specific IgG, IgG2c and IgG1 titers in Sfpi1lck−/− 
mice compared to wild type mice on day 25 (Figure 4D). The enhanced germinal center 
activity in Sfpi1lck−/− mice suggests that PU.1 is a negative regulator of Tfh cells and 
indirectly GCB cell formation and without PU.1 expression in Tfh cells, the resolution of 
germinal center activity is attenuated.
Increased germinal center formation in the absence of PU.1 following SRBC immunization
The MOG35-55-immunization experiments were performed in the context of examining EAE 
in mice that lack PU.1 expression in T cells. We observed that Sfpi1lck−/− mice had greater 
disease severity through an as yet undetermined mechanism (data not shown). To further 
define the effects of PU.1-deficiency on Tfh development in a model that does not have an 
ongoing inflammatory disease and in an adjuvant-independent manner, we used 
immunization with sheep red blood cells (SRBCs). SRBCs are highly immunogenic, 
resulting in a robust GC activity, allowing for the study of greater numbers of Tfh cells.
We first wanted to examine PU.1 expression in a Tfh population from immunized mice. We 
sorted the Tfh (CD4+CXCR5+PD-1+), non-Tfh (CD4+CXCR5−PD-1-low) and naïve T 
(CD4+ CD62L+) cell populations from wild type mice and analyzed PU.1 expression by 
qPCR. PU.1 expression was higher in Tfh cells compared to non-Tfh cells, but was not 
significantly different from PU.1 expression in naïve CD4 T cells (Figure 5A).
We then examined Tfh and GCB cells seven and ten days after SRBC immunization. 
Sfpi1lck−/− mice showed higher percentages and absolute numbers of Tfh and GCB cells 
compared to wild type mice seven days after immunization, with no significant differences 
in total splenic cellularity (Figure 5B-E). On day 10, the percentage of Tfh cells in Sfpi1lck−/
− mice and wild type mice was similar, however, the absolute numbers of Tfh cells, and the 
percentages and absolute numbers of GCB cells in Sfpi1lck−/− mice was significantly higher 
than in wild type mice (Figure 5B-E). Tfh cells from Sfpi1lck−/− mice also showed 
significantly higher levels of PD-1 and ICOS on both day 7 and day 10 (Figure 5F).
To further understand what factors may be contributing to the increase in GCB cells in 
Sfpi1lck−/− mice, we looked at the expression of CD40L and IL-21 in Tfh cells from 
Sfpi1lck−/− and wild type mice. Tfh cells from Sfpi1lck−/− mice had increased expression of 
intracellular CD40L compared to wild type mice (Figure 6A-B). Sfpi1lck−/− Tfh cells also 
had a higher percentage of IL-21-positive Tfh cells with a higher MFI compared to wild type 
mice (Figure 6C-D and data not shown). The number of IL-21-positive cells within the 
spleen of Sfpi1lck−/− mice was two-fold larger than the number seen in wild type mice 
(Figure 6E). Apart from the increased CD40L and IL-21 expression by Sfpi1lck−/− Tfh cells 
the increase in GCB cells in immunized Sfpi1lck−/− could also be due to decreased follicular 
regulatory cells. However, the percentage of T follicular regulatory cells within the spleens 
of Sfpi1lck−/− and wild type mice were similar (data not shown). SRBC protein specific 
IgG1 and IgG2c antibody titers were also significantly elevated in Sfpi1lck−/− mice 
compared to wild type mice (Figure 6F-G).
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We next determined if there were alterations in the expression of other Tfh-associated genes 
caused by the absence of PU.1, we sorted Tfh cells (CD4+CXCR5+PD-1+) from Sfpi1lck−/− 
and wild type mice 7 days after SRBC immunization. Sfpi1lck−/− Tfh cells showed a 
significant increase in Tbx21 mRNA expression (Figure 7), consistent with previous reports 
of increased T-bet expression in IL-21-secreting Tfh cells (38) . We also observed that 
Sfpi1lck−/− Tfh cells showed a significant increase in Bcl6 and Maf expression (Figure 7). 
Sfpi1lck−/− Tfh cells also showed a decrease in Irf4 mRNA expression (Figure 7). Although 
this decrease is significant, the requirement for IRF4 in Tfh cell development suggests the 
decrease has only a modest biological effect (39). We did not observe any difference in 
Gata3, Ifng, or Il4 expression by wild type and Sfpi1lck−/− Tfh cells (Figure 7). Together, 
these data indicate an important requirement for PU.1 in limiting Tfh development and 
regulating multiple genes within the Tfh population.
Blocking CD40L in Sfpi1lck−/− mice decreases Germinal Center B cells and restores 
normal Immunoglobulin levels
CD40L and IL-21 both play an important role in the expansion of GCB cells. However, the 
absence of CD40L expression in humans and mice appears to have a more dramatic impact 
on GC development and subsequently B-cell function (19, 20, 29, 40-44). We used blocking 
antibodies against IL-21 or CD40L to determine if either factor was contributing to the 
enhanced development of GCB cells seen in Sfpi1lck−/− mice. We immunized Sfpi1lck−/− 
mice with SRBC and injected mice with IL-21 blocking antibodies on days 2, 4, and 6. On 
day 7 mice were sacrificed and GC Tfh and B cells were assessed. We found that blocking 
IL-21 did not change the number of GCB cells in wild type or Sfpi1lck−/− mice (data not 
shown). We next blocked CD40L activity after SRBC immunization by treating Sfpi1lck−/− 
and wild type mice with control antibody or antibodies against CD40L. Blocking CD40L 
significantly decreased the number of GCB cells in Sfpi1lck−/− (Figure 8A). Yet, the dose 
used in these experiments had only a modest effect on wild type GCB cell development, 
suggesting that GCB cells in Sfpi1lck−/− mice were more sensitive to this treatment (Figure 
8A). Despite the reduction in GCB cells in Sfpi1lck−/− mice that received CD40L blocking 
antibody, there were still elevated GCB cell numbers in Sfpi1lck−/− mice compared to wild 
type mice that received control antibody. We observed a slight but not statistically 
significant decrease in Tfh cells in Sfpi1lck−/− mice after CD40L antibody treatment (Figure 
8B). To determine if the CD40L-mediated reduction in GCB cells was reflected in function, 
we analyzed the titers of IgG2c in mice that received control and CD40L blocking 
antibodies. Anti-CD40L treatment attenuated the increase in IgG2c compared to Sfpi1lck−/− 
mice that received control antibody (Figure 8C). The titers of IgG2c observed in Sfpi1lck−/− 
mice that received anti-CD40L antibody was indistinguishable from titers observed in wild 
type mice (Figure 8C). Thus, PU.1 negatively regulates Tfh cell development and controls 
GCB cell numbers by a mechanism that is at least partly dependent upon CD40L.
Discussion
Mounting a lasting immune response against invading organisms is a key component of the 
adaptive immune response. Tfh cells and GCB cells are vital factors in the production of 
high affinity antibodies during an initial infection and later during subsequent infections. A 
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balance of initiation and resolution of the germinal center response is required for prevention 
of recurrent or persistent infections or on the other side of the spectrum, autoimmunity. 
Therefore, a comprehensive understanding of the factors that positively or negatively 
regulate germinal center activity is vital. Tfh cells express the surface proteins that facilitate 
cognate B cell interactions within the germinal center. Among the proteins that facilitate 
these interactions, CD40L and IL-21 are principal orchestrators within germinal centers that 
enable Tfh cells to provide help to B cells. Yet, how CD40L and IL-21 are regulated in Tfh 
cells is not completely understood.
The observations in this report suggest that PU.1 is a regulator of Tfh activity, at least 
partially through regulation of CD40L. We observed that ectopic expression of PU.1 in CD4 
T cells represses Tnfsf5 mRNA and CD40L surface expression. PU.1 bound directly to the 
Tnfsf5 promoter, and T cells that lack PU.1 expression have increased CD40L expression. In 
two different models of antibody production, both adjuvant-dependent and –independent, 
mice with PU.1-deficient T cells had increased frequency and number of Tfh cells and GCB 
cells, and increased IgG production. Importantly, antibodies to CD40L diminished GCB cell 
numbers and antibody production, suggesting a sensitivity to blockade of this surface ligand. 
Preliminary experiments with in vitro-derived Tfh-like cells demonstrated that PU.1-
deficient Tfh-like cells have an increased ability to induce IgG2c production during an in 
vitro culture assay where cell numbers are normalized (data not shown). Thus, at least some 
of the effects we observe on in vivo Tfh function appear to be intrinsic to the population. 
However, some of the increased function of PU.1-deficient Tfh cells might be due to 
increased numbers of cells.
It is still not entirely clear how PU.1 mediates the expansion of the Tfh population. It is 
possible that PU.1 regulates one of the surface receptors studied in this report, which impact 
GCB cell expansion that subsequently feeds back to promote Tfh expansion. We noted that 
although CD40L blockade decreased GCB cell expansion and IgG production, it did not 
significantly inhibit Tfh numbers. This could be due to an insufficient concentration of anti-
CD40L to completely block the effects of the interaction, but might also indicate another 
mechanism. We have previously shown that the absence of PU.1 in CD4+ T cells leads to 
increased TCR expression and increased T cell activation (22). Although T-cell receptor 
(TCR) signaling is necessary for multiple stages of Tfh and germinal center development 
(45, 46), we also observed that increased stimulation of PU.1-deficient CD4 T cells results 
in increased IL-2 production, a cytokine known to inhibit Tfh development (39). Thus, it 
seems unlikely that the TCR regulatory function of PU.1 contributes to the Tfh phenotype in 
vivo.
We present evidence that shows PU.1 is important for regulating IL-21 expression by Tfh 
cells. Although IL-21 did not appear to be responsible for the increased Tfh activity in the 
absence of PU.1-expressing T cells, PU.1 bound the Il21 promoter, and PU.1-dependent 
regulation of IL-21 production was observed in vitro and in vivo. IL-21 expression by Tfh 
cells has been shown to be downstream of ICOS and c-maf (9). Ectopic expression of PU.1 
in CD4+ T cells leads to decreased Il21 and Maf mRNA, but not ICOS. Our in vivo studies 
show increased expression of IL-21 protein and Maf mRNA in Sfpi1lck−/− Tfh cells, 
compared to controls. These reports, coupled with the data that PU.1 binds the Il21 
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promoter, suggests that PU.1-dependent regulation could be both direct, and indirect, 
through c-Maf. PD-1 expression was also decreased by ectopic PU.1 expression and Tfh 
cells in Sfpi1lck−/− mice express greater amounts of PD-1. However, we did not detect PU.1 
binding to the Pdcd1 promoter, suggesting that either PU.1 binds to a separate regulatory 
region, or that PD-1 is regulated indirectly, possibly through regulation of BCL6 (47).
Our findings also suggest that changes in the expression of PU.1 in T cells might play a role 
in autoimmunity. Gene association studies have linked increased PU.1 expression in CD4+ 
T cells to systemic lupus erythematosus (48) and the ability of PU.1 to alter Tfh functions 
might be a potential mechanism for increased autoantibody production. Moreover, the ETS 
DNA recognition motif is enriched in sequences near enhancer regions associated with 
human Tfh cell gene regulation (49). These data would suggest that altered PU.1 expression 
might contribute to autoantibody production in patient populations.
This report provides greater evidence for the involvement of PU.1 in germinal center B-cell 
development and antibody production. We show that PU.1 has intrinsic functions within the 
Tfh population and that PU.1-deficiency results in altered expression of CD40L, IL-21 and 
transcription factors including Maf and Irf4. This might parallel the ability of PU.1 to recruit 
Bcl6 and repress genes in GCB cells (50). Moreover, the effects of PU.1 deficiency in T 
cells impact GCB cell development, expansion and antibody production. Whether the ability 
of PU.1 to regulate antibody production leads to altered risk of autoimmunity is not clear 
and will be an important question for the future.
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Figure 1. 
PU.1-dependent gene regulation in CD4+ T-cells. A, Naïve wild type CD4 T cells were 
cultured under Th2 conditions and transduced with control retrovirus or retrovirus 
expressing PU.1. Changes in expression of genes displayed as the ratio of expression of 
genes in CD4+ T-cells ectopically expressing PU.1 relative to expression in control vector 
transduced cells. B, Naïve wild type CD4 T cells were cultured under Tfh-like conditions 
and transduced with control retrovirus or retrovirus expressing PU.1. After five days of 
culture, transduced cells were stimulated with PMA and Ionomycin for 5 hours and stained 
for PD-1 and CD40L. Histograms indicate PD-1 and CD40L expression. Numbers indicate 
MFI. C, Naïve cells from Sfpi1lck−/− mice were cultured under Th17conditions and 
retrovirally transduced with an empty control vector (MIEG-GFP), or a vector expressing 
the PU.1 gene, MIEG-Sfpi1. After 5 days of culture, cells were sorted by GFP expression 
and restimulated with anti-CD3. Supernatants were collected and IL-21, IL-17a, and IFN-γ 
secretion was measured by ELISA. Data are representative of 3-5 mice/group. D, Chromatin 
immunoprecipitation was performed from wild type and Sfpi1lck−/− activated T cells 
cultured for three days. Chromatin was immunoprecipitated with anti-PU.1 and isolated 
DNA was identified with quantitative PCR for promoter regions of the indicated genes. 
Statistical significance was determined with a two-tailed t test, *, p<0.05.
Awe et al. Page 14
J Immunol. Author manuscript; available in PMC 2016 October 15.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. 
CD4+ T-cells from Sfpi1lck−/− mice show increased CD40L and IL-21 expression in vitro. 
Total CD4+ T-cells from Sfpi1lck−/− and WT mice were stimulated with PMA + Ionomycin 
for 2 hours. A, Flow cytometric analysis of intracellular staining for CD40L. The average 
percent of CD4+CD40L+ cells (B) and histograms of the MFI of CD40L+ cells (C) are 
indicated. D, Naïve cells CD4+CD62L+ were isolated from WT and Sfpi1lck−/− mice and 
cultured under Th1, Th2, Th9, Th17, and T-regulatory conditions. Concentrations of IL-21 
(D) produced by the indicated Th subsets, and IL-17A (E) produced by Th17 cells was 
measured by ELISA. F, Naïve cells from wild type and Sfpi1lck−/− mice were cultured 
under Tfh conditions. After 3 days of culture cells were restimulated with PMA and 
Ionomycin for 5 hours and surface and intracellular cytokine staining was conducted. 
Contour plots indicate PD-1 and IL-21 staining and graphs indicate the average of values 
from 3 mice. Data are representative of 3-5 mice/experiments. Statistical significance was 
determined with a two-tailed t test, *, p<0.05.
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Figure 3. 
Sfpi1lck−/− mice have increased Tfh cells after immunization with MOG35-55. WT and 
Sfpi1lck−/− mice were immunized with MOG35-55 and sacrificed 12, 25, and 28 days after 
initial immunization. A, Spleens from immunized mice were harvested from wildtype and 
Sfpi1lck−/− mice for mRNA analysis. mRNA levels of the indicated genes 12 and 25 days 
after immunization are shown. B, Splenocytes from immunized mice were stained for Tfh 
markers and analyzed by flow cytometry. C, Percent of Tfh and number of Tfh cells in wild 
type and Sfpi1lck−/− mice 12, 25 and 28 days after immunization are shown. D, PD-1 and 
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ICOS expression by WT and Sfpi1lck−/− Tfh cells were measured by flow cytometry. Data 
are representative of 2-3 experiments with 3-6 mice per group (A-D). Statistical significance 
was determined with a two-tailed t test, *, p<0.05; **, p<0.005.
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Figure 4. 
Sfpi1lck−/− mice have enhanced germinal center B-cell development after MOG35-55 
immunization. WT and Sfpi1lck−/− mice were immunized with MOG35-55 and analyzed 12, 
25, and 28 days after immunization. A, Splenocytes were stained with germinal center B-
cell markers and analyzed flow cytometry. B, Percent of GC B-cells and number of GC B-
cells in wild type and Sfpi1lck−/− mice are indicated. C-D, Serum IgG, IgG2c, and IgG1 
titers were measured on days 12 (C) and 25 (D). Data are representative of 2-3 experiments 
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with 3-6 mice per group (A-C). Statistical significance was determined with a two-tailed t 
test, *, p<0.05; **, p<0.005.
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Figure 5. 
Tfh and GC B cell analysis in WT and Sfpi1lck−/− mice after SRBC immunization. WT and 
Sfpi1lck−/− mice were immunized with SRBC for analysis of germinal center activity. A, 
Naïve, CD4+CXCR5+PD-1+Tfh cells, and CD4+CXCR5−PD-1− Non-Tfh cells were sorted 
from wild type spleen and mRNA was isolated for analysis of gene expression. B, 
Splenocytes from SRBC immunized mice were stained for Tfh cell analysis by flow 
cytometry. C, The average frequency and number of Tfh cells 7 and 10 days after 
immunization are indicated. D, Splenocytes from SRBC immunized mice were stained for 
GC B cells. E, The average frequency and number of GCB cells 7 and 10 days after SRBC 
immunization are shown. F, PD-1 and ICOS expression on Tfh cells 7 and 10 days after 
immunization are shown. Data are representative of 2 experiments with 6 mice per group 
(A) and 2 experiments (B-D) with 8 mice per group. Statistical significance was determined 
with a two-tailed t test, *,p<0.05; ***, p<0.0001.
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Figure 6. 
Gene expression and antibody production in WT and Sfpi1lck−/− mice after SRBC 
immunization. WT and Sfpi1lck−/− mice were immunized with SRBC and stained for 
CD40L and IL-21 expression in Tfh cells. CD40L (A,B) and IL-21 (C,D) expression by WT 
and Sfpi1lck−/− Tfh cells was determined by flow cytometry. (E) The percentage of 
CD4+CXCR5+ PD-1High cells that are IL-21+ was determined by flow cytometry. Serum 
from SRBC immunized WT and Sfpi1lck−/− mice were collected and IgG1 (F) and IgG2c (G) 
titers for SRBC protein specific antibodies were determined by ELISA. Data are 
representative of 2 experiments with 5-6 mice per group (A-D) and 2 experiments with 6 
mice per group (C-G). Statistical significance was determined with a two-tailed t test. *, 
p<0.05.
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Figure 7. 
Gene expression analysis of sorted Tfh cells from SRBC immunized WT and Sfpi1lck−/− 
mice. Tfh and Non-Tfh cells were sorted from SRBC immunized WT and Sfpi1lck−/− mice 
and expression of the indicated genes was determined by qPCR. Data are representative of 2 
experiments with 6 mice per group. Statistical significance was determined with a two-tailed 
t test. *, p<0.05.
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Figure 8. 
Blocking of CD40L attenuates germinal center B-cell increases in Sfpi1lck−/− mice. WT and 
Sfpi1lck−/− mice were immunized with SRBC and treated with control antibody or CD40L 
blocking antibody on days 5 and 6 post-immunization. On day 7 mice were sacrificed and 
splenocytes analyzed for Tfh cells and GCB cells by flow cytometry. The total number of 
GCB cells (A) and Tfh cells (B) are indicated. (C) SRBC protein specific IgG2c titers were 
analyzed by ELISA. Data are representative of 2 experiments with 4-8 mice per group (A-
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C). Statistical significance was determined with one way ANOVA (A) and two-tailed t test 
(B-C), *, p<0.05; ***, p<0.0001.
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